Umban, Shirlyn A.

HRN: 29-08-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/22/2026
06/28/2026
IV
500mg
Q6
Infected Wound Inguinal Area Right
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines